A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Hutchmed
Bayer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eisai Inc.
Bristol-Myers Squibb
Eisai Inc.
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Boehringer Ingelheim
Celgene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)